Related Experiment Video
Updated: Aug 5, 2026
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Evaluating the Urinary Exosome MicroRNA Profile in Prostate Cancer
Beatriz Walter Rodriguez1, Christopher J Ricketts2, Baris Turkbey3
1Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Genes
|July 28, 2026
Summary
Urine exosomal microRNAs (miRNAs) show promise as prostate cancer biomarkers. Specific miRNA profiles can detect prostate cancer and predict its clinical features, though some markers may indicate general urologic cancer.
Area of Science:
- Urology
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Prostate cancer is a leading cause of cancer death globally, necessitating improved diagnostic and surveillance tools.
- Liquid biopsies, particularly urine-derived exosomal microRNAs (miRNAs), offer a non-invasive approach for prostate cancer detection.
Purpose of the Study:
- To investigate urine-derived exosomal miRNA profiles for prostate cancer identification.
- To assess the potential of these miRNAs in predicting clinical features of prostate cancer.
- To differentiate prostate cancer-specific miRNA signatures from those of other urologic cancers.
Main Methods:
- Urine samples were collected from prostate cancer patients, healthy controls, and patients with clear cell renal cell carcinoma (ccRCC) due to von Hippel-Lindau (VHL) syndrome.
- Exosomes were isolated from urine, and transcriptomic analysis was performed to profile exosomal miRNAs.
- Comparative analysis of miRNA expression patterns was conducted across the different patient groups.
Main Results:
- Distinct urine-derived exosomal miRNA profiles were observed in prostate cancer patients compared to controls.
- Specific miRNAs (miR-122-5p, miR-125-5p, miR-16-5p) showed altered expression in prostate cancer.
- Several miRNAs (miR-30a-5p, miR-320 family) were upregulated/downregulated in both prostate cancer and ccRCC, suggesting non-specific urologic cancer markers.
- Certain miRNA expressions correlated with extracapsular or perineural invasion, indicating prognostic potential.
Conclusions:
- Urine-derived exosomal miRNAs hold potential as biomarkers for prostate cancer diagnosis and predicting clinical features.
- Some identified miRNA signatures may serve as non-specific indicators for various urologic cancers.
- Further validation studies are crucial to establish the clinical utility of these exosomal miRNA biomarkers.
